StatPearls, LLC

  • Aldosterone
  • Fludrocortisone
  • Hyperkalemia
  • Hypoaldosteronism
  • Pseudohypoaldosteronism

Hypoaldosteronism

Hypoaldosteronism encompasses a spectrum of endocrine disorders marked by deficient aldosterone synthesis, release, or activity, disrupting sodium retention, potassium excretion, and fluid balance. This condition arises from genetic causes, acquired conditions, or medication-induced etiologies. Pseudohypoaldosteronism, characterized by aldosterone resistance, complicates diagnosis due to elevated aldosterone levels with ineffective action. Clinical manifestations include hyperkalemia, hyponatremia, metabolic acidosis, and hypotension, particularly in high-risk groups like infants in salt-wasting crises, patients with chronic kidney disease, or those with diabetes. Diagnosis relies on biochemical testing, genetic markers, and renin-aldosterone ratios. Untreated, hypoaldosteronism leads to life-threatening electrolyte imbalances and cardiovascular instability. Management involves mineralocorticoid replacement, potassium management, and addressing underlying causes, with careful monitoring to prevent complications across diverse patient populations. This educational activity enhances clinicians competence in diagnosing and managing hypoaldosteronism by deepening understanding of its pathophysiology, including aldosterone synthesis, renin-angiotensin-aldosterone system regulation, and genetic or medication-induced causes. Participants learn to recognize clinical presentations and high-risk populations, interpret biochemical patterns, and implement evidence-based treatments like fludrocortisone or sodium supplementation. The course emphasizes diagnostic strategies, such as critical sampling and genetic testing, to differentiate hypoaldosteronism from pseudohypoaldosteronism. Interprofessional collaboration with endocrinologists, nephrologists, geneticists, and pharmacists enhances patient outcomes by ensuring accurate diagnosis through coordinated testing, tailored therapies, and monitoring for complications like hyperkalemia. This team approach reduces diagnostic…

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 2 creditsAAPA Category 1 Credit™Up to 2 creditsAMA PRA Category 1 Credit™Up to 2 creditsNursingUp to 2 creditsPharmacyUp to 2 credits

MOC types

ABS — Accredited CMEUp to 2 pointsABPATH — Lifelong LearningUp to 2 pointsABA — Lifelong LearningUp to 2 pointsABTS — Accredited CMEUp to 2 pointsABIM — Medical KnowledgeUp to 2 pointsABS — Self-AssessmentUp to 2 pointsABP — Lifelong Learning and Self-AssessmentUp to 2 pointsABTS — Self-AssessmentUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 10 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • includes Board review / self-assessment
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left